Istituto Cardiocentro Ticino

Running trials

• Recruiting

  Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

  NCT07582835· Phase 3· Cardiocentro Ticino· Source

• Recruiting

  Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters

  NCT07130773· Cardiocentro Ticino· Source

• Recruiting

  Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction

  NCT07077057· Cardiocentro Ticino· Source

• Active, not recruiting

  A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation

  NCT06808217· Boston Scientific Corporation· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Recruiting

  Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

  NCT06779630· Teleflex· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Not yet recruiting

  Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.

  NCT06928883· Cardiocentro Ticino· Source

• Recruiting

  Minimally Invasive Coronary Artery Bypass Supported by Cangrelor

  NCT07514962· Cardiocentro Ticino· Source

• Recruiting

  Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

  NCT05955365· Phase 4· Insel Gruppe AG, University Hospital Bern· Source

• Active, not recruiting

  Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

  NCT05705973· Terumo Europe N.V.· Source

• Active, not recruiting

  Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

  NCT04763200· Abiomed Inc.· Source

• Recruiting

  In-hospital Stellate Ganglion Block for Arrhythmic Storm

  NCT05720936· Fondazione IRCCS Policlinico San Matteo di Pavia· Source

• Active, not recruiting

  REDUCER-I: An Observational Study of the Neovasc Reducer™ System

  NCT02710435· Shockwave Medical, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease4 recruiting
• Atrial fibrillation2 recruiting
• Heart failure1 recruiting
• Obesity1 recruiting

Closed trials

• Recruiting

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  NCT06059638· Orchestra BioMed, Inc· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

  NCT04236609· Concept Medical Inc.· Source

• Completed

  The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment

  NCT03654573· Phase 1· CorFlow Therapeutics AG· Source

• Completed

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· Phase 3· CSL Behring· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Ventricular tachycardia12 works · 1 trial